New Delhi: Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech’s COVID-19 vaccine Covaxin for the beneficiaries aged between 2-18 years, the official sources said. Earlier, Dr Sanjay K Rai, a professor at Centre for Community Medicine, All India Institute of Medical […]
